COO The Cooper Companies, Inc. - Common Stock
Über The Cooper Companies, Inc. - Common Stock Unternehmensübersicht von Wikipedia
Die The Cooper Companies Inc. mit Hauptsitz in Pleasanton, Kalifornien ist ein US-amerikanisches Unternehmen in der Gesundheitsbranche.
Mehr lesen
Die The Cooper Companies Inc. mit Hauptsitz in Pleasanton, Kalifornien ist ein US-amerikanisches Unternehmen in der Gesundheitsbranche.
The Cooper Companies ist weltweit einer der größten Hersteller von Kontaktlinsen, insbesondere im Segment der torischen Speziallinsen. Die Kontaktlinsen von Cooper Companies werden in sieben unternehmenseigenen Produktionsstätten gefertigt, u. a. in Rochester, Adelaide und Madrid.
Größere Vertriebszentralen des Unternehmens befinden sich im Vereinigten Königreich und in den USA.
Struktur
CooperVision
CooperVision ist eine Gesellschaft der Cooper Companies. Die Hälfte seiner 20 Niederlassungen ist in Europa ansässig. CooperVision beschäftigt weltweit ca. 8.600 Mitarbeiter, davon allein 2.500 in den europäischen Ländern, und unterhält sieben unternehmenseigene Produktionsstätten an internationalen Standorten. Geschäftszweck von CooperVision ist vor allem die Produktion von Kontaktlinsen.
2011 kündigte CooperVision eine neue Markenpositionierung und visuelle Erscheinung an, welche von Siegel+Gale, einer weltweit tätigen Branding-Firma, entwickelt wurde. Dieses Rebranding gewann 2012 als eine von fünf Unternehmen den „Best of Awards“ von REBRAND. Im Jahr 2013 arbeiteten Forscher von CooperVision in Zusammenarbeit mit Linköpings Universität (Schweden), der Universität von Ottawa (Kanada), FibroGen Inc (USA) und Synsam Opticians (Schweden) an einer Studie zu künstlichen Hornhäuten. Diese Studie wurde in der Zeitschrift Science Translational Medicine veröffentlicht, außerdem hat die BBC (British Broadcasting Corporation) in einem Beitrag darüber berichtet.
CooperSurgical
Cooper Surgical stellt verschiedene Medizinprodukte mit Schwerpunkt auf medizinische Produkte für Frauen.
Unternehmensgeschichte
Cooper Companies Inc. wurde 1958 ursprünglich als Martin H. Smith Co. gegründet, 1967 wurde der Firmenname zu Cooper Laboratories Inc. geändert. Im Jahre 1978 kam es zu einer Reorganisierung in Cooper Laboratories, Cooper Medical Devices, Cooper Dental, Cooper International und CooperVision. CooperVision wurde 1980 als Aktiengesellschaft (Inc) eingetragen und der Börsengang erfolgte 1983. CooperVision Inc. veränderte 1987 erneut den Namen zu The Cooper Companies Inc. und untergliederte sich in 3 Geschäftsbereiche: Cooper Technicon, CooperSurgical und CooperVision.
Die Aktionäre der beiden Unternehmen The Cooper Companies und Ocular Sciences (OSI) haben am 16. November 2004 der Übernahme von OSI zugestimmt. Die Aufsichtsbehörden hatten die Zustimmung erteilt und das Abschlussdatum damit festgesetzt. Mit diesem Datum ging das Eigentum von Ocular Sciences auf den Geschäftsbereich CooperVision über. Mit der Übernahme von Ocular Sciences ist der amerikanische Kontaktlinsenhersteller CooperVision seit Beginn des Jahres 2005 auch auf dem deutschen Markt vertreten.
Wichtige Produkte
CooperVision entwickelt, erzeugt und vermarktet weltweit eine breite Palette von Kontaktlinsen, darunter auch eine biokompatible Kontaktlinsenfamilie. Das hierfür verwendete Kontaktlinsenmaterial Omafilcon A enthält als Polymerbestandteil eine synthetische Kopie des Stoffes Phosphorylcholin, kurz PC genannt. Phosphorylcholin kommt als Molekülbestandteil in allen menschlichen, tierischen und pflanzlichen Zellen vor und findet in der Biomedizin, so z. B. in Bypässen, bereits seit geraumer Zeit Anwendung, da es als körpereigener Stoff erkannt wird.
Soziales Engagement
CooperVision ist an verschiedenen Projekten und Stipendienprogrammen beteiligt.
Das Unternehmen vergibt ein Studien-Forschungsstipendium, welches Optometrie-Studenten ermutigen soll, sich an Kontaktlinsen-basierten Forschungsprojekten zu beteiligen.
Im Jahr 2012 spendeten The Cooper Companies, Inc. und CooperVision 100.000 US-Dollar an die Optometry Giving Sight World Sight Day Challenge.
CooperVision ist ein Gründungsschirmherr und Sponsor des Optometry Giving Sight, einem globalen Spenden-Programm, welches zum Ziel hat, weltweit den Zugang zu Augenuntersuchungen und Brillen zu erleichtern.
Das Unternehmen initiierte auch die One Bright Vision-Kampagne in Partnerschaft mit Optometry Giving Sight.
Auszeichnungen
CooperVision erhielt im Jahr 2013 für die Kontaktlinsen MyDay den Preis SILMO d’Or.
Niederlassungen in Europa
Frankreich Frankreich: Sophia Antipolis
Deutschland Deutschland: Darmstadt
Italien Italien: Lainate
Niederlande Niederlande: Gorinchem
Schweden Schweden: Stockholm
Schweden Schweden: Mölndal
Vereinigtes Konigreich Vereinigtes Königreich: Hamble-le-Rice, Borough of Eastleigh
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
COO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
COO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag |
|---|---|
| 26. Juli 2023 | $0,0075 |
| 20. Januar 2023 | $0,0075 |
| 26. Juli 2022 | $0,0075 |
| 20. Januar 2022 | $0,0075 |
| 26. Juli 2021 | $0,0075 |
| 21. Januar 2021 | $0,0075 |
| 22. Juli 2020 | $0,0075 |
| 22. Januar 2020 | $0,0075 |
| 22. Juli 2019 | $0,0075 |
| 18. Januar 2019 | $0,0075 |
| 20. Juli 2018 | $0,0075 |
| 22. Januar 2018 | $0,0075 |
| 19. Juli 2017 | $0,0075 |
| 19. Januar 2017 | $0,0075 |
| 20. Juli 2016 | $0,0075 |
| 20. Januar 2016 | $0,0075 |
| 22. Juli 2015 | $0,0075 |
| 21. Januar 2015 | $0,0075 |
| 22. Juli 2014 | $0,0075 |
| 22. Januar 2014 | $0,0075 |
COO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
- Starker Kauf 6 26,1%
- Kauf 7 30,4%
- Halten 10 43,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
14 Analysten · 2026-08-16Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $1.21 | $1.11 | 0.10% |
| 31. März 2026 | $1.10 | $1.04 | 0.06% |
| 31. Dezember 2025 | $1.15 | $1.12 | 0.03% |
| 30. September 2025 | $1.10 | $1.08 | 0.02% |
| 30. Juni 2025 | $0.96 | $0.94 | 0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| COO | $13.70B | 37.4 | 5.1% | 9.2% | 4.6% | 65.5% |
| MDLN | — | -4200.0 | 11.5% | 4.1% | 21.6% | 26.4% |
| SOLV | $13.75B | 8.9 | 0.86% | 18.7% | 35.8% | 53.5% |
| ALGN | $11.14B | 27.6 | 0.90% | 10.2% | 10.3% | 67.2% |
| LNTH | $4.30B | 19.5 | 0.50% | 15.2% | 20.7% | 61.1% |
| MMED | $3.71B | -10.2 | 14.2% | -10.7% | -9.3% | 54.2% |
| MMSI | $5.24B | 41.4 | 11.8% | 8.5% | 8.4% | 48.7% |
| HAE | $2.45B | 26.4 | -2.0% | 7.3% | 11.8% | 59.0% |
| ICUI | $3.52B | 4755.7 | -6.3% | 0.03% | 0.03% | 36.8% |
| QDEL | $1.99B | -1.8 | -1.9% | -41.4% | -48.0% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B | $2.14B | $1.97B | $1.80B | $1.72B | |
| Cost of Revenue | $1.41B | $1.30B | $1.24B | $1.17B | $967M | $896M | $897M | $900M | $773M | $794M | $727M | $626M | |
| Gross Profit | $2.68B | $2.60B | $2.36B | $2.14B | $1.96B | $1.53B | $1.76B | $1.63B | $1.37B | $1.17B | $1.07B | $1.09B | |
| R&D Expense | $172M | $155M | $137M | $110M | $93M | $93M | $87M | $85M | $69M | $65M | $70M | $66M | |
| SG&A Expense | $1.63B | $1.53B | $1.50B | $1.34B | $1.21B | $992M | $996M | $973M | $799M | $723M | $712M | $683M | |
| Operating Income | $683M | $706M | $533M | $508M | $506M | $312M | $547M | $403M | $429M | $324M | $237M | $306M | |
| Interest Expense | · | · | $105M | $57M | $23M | $37M | $68M | $83M | $33M | $26M | $18M | $8M | |
| Other Non-op | $-16M | $-9M | $-15M | $25M | $9M | $-8M | $-1M | $12M | $-2M | $-2M | $-3M | $-2M | |
| Pretax Income | $566M | $582M | $413M | $475M | $492M | $266M | $477M | $332M | $394M | $296M | $216M | $296M | |
| Income Tax | $192M | $190M | $119M | $90M | $-2.45B | $28M | $11M | $192M | $21M | $21M | $10M | $25M | |
| Net Income | $375M | $392M | $294M | $386M | $2.94B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | |
| EPS (Basic) | $1.88 | $1.97 | $1.49 | $1.95 | $59.80 | $4.85 | $9.44 | $2.85 | $7.63 | $5.65 | $4.20 | $5.61 | |
| EPS (Diluted) | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 | $4.81 | $9.33 | $2.81 | $7.52 | $5.59 | $4.14 | $5.51 | |
| Shares (Basic) | 199,100,000 | 198,900,000 | 197,900,000 | 197,400,000 | 49,200,000 | 49,100,000 | 49,400,000 | 49,100,000 | 48,900,000 | 48,500,000 | 48,500,000 | 48,061,000 | |
| Shares (Diluted) | 200,000,000 | 200,400,000 | 199,300,000 | 198,800,000 | 49,800,000 | 49,600,000 | 50,000,000 | 49,700,000 | 49,600,000 | 49,000,000 | 49,200,000 | 49,000,000 | |
| EBITDA | $1.06B | $1.08B | $901M | $508M | $506M | $312M | $828M | $678M | $618M | $522M | $428M | $445M |
Bilanz 29
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $111M | $108M | $121M | $138M | $96M | $116M | $89M | $78M | $89M | $101M | $16M | $25M | |
| Receivables | $829M | $717M | $610M | $558M | $515M | $435M | $435M | $375M | $317M | $291M | $283M | $276M | |
| Inventory | $846M | $803M | $736M | $629M | $586M | $570M | $507M | $469M | $454M | $418M | $420M | $382M | |
| Prepaid Expense | $321M | $324M | $239M | $209M | $179M | $152M | $132M | $170M | $94M | $78M | $81M | $68M | |
| Current Assets | $2.11B | $1.95B | $1.70B | $1.53B | $1.47B | $1.27B | $1.16B | $1.09B | $953M | $937M | $841M | $792M | |
| PP&E (Net) | $2.08B | $1.86B | $1.63B | $1.41B | $1.35B | $1.28B | $1.13B | $976M | $910M | $878M | $967M | $937M | |
| PP&E (Gross) | $3.91B | $3.56B | $3.18B | $2.80B | $2.66B | $2.47B | $2.19B | $1.93B | $1.76B | $1.60B | $1.65B | $1.53B | |
| Accum. Depreciation | $1.83B | $1.70B | $1.55B | $1.39B | $1.31B | $1.19B | $1.06B | $954M | $847M | $726M | $684M | $589M | |
| Goodwill | $3.85B | $3.84B | $3.62B | $3.61B | $2.57B | $2.45B | $2.43B | $2.39B | $2.35B | $2.16B | $2.20B | $2.22B | |
| Intangibles | $1.59B | $1.79B | $1.71B | $1.89B | $1.27B | $1.29B | $1.41B | $1.52B | $505M | $441M | $411M | $454M | |
| Other Non-current Assets | $689M | $661M | $637M | $588M | $401M | $105M | $67M | $74M | $76M | $52M | $39M | $39M | |
| Total Assets | $12.39B | $12.32B | $11.66B | $11.49B | $9.61B | $6.74B | $6.27B | $6.11B | $4.86B | $4.48B | $4.46B | $4.46B | |
| Accounts Payable | $300M | $260M | $262M | $249M | $161M | $176M | $150M | $146M | $142M | $107M | $117M | $116M | |
| Short-term Debt | $47M | $32M | $44M | $396M | $83M | $409M | $564M | $37M | $23M | $226M | $244M | $102M | |
| Current Liabilities | $1.11B | $1.02B | $969M | $1.28B | $732M | $1.00B | $1.11B | $536M | $396M | $543M | $569M | $442M | |
| Capital Leases | $240M | $231M | $216M | $206M | $232M | $237M | · | · | · | · | · | · | |
| Deferred Tax | $93M | $96M | $102M | $150M | $24M | $26M | $28M | $31M | $39M | $38M | $31M | $70M | |
| Other Non-current Liabilities | $283M | $312M | $239M | $225M | · | · | · | · | · | · | · | · | |
| Total Liabilities | $4.16B | $4.23B | $4.11B | $4.32B | $2.66B | $2.91B | $2.65B | $2.81B | $1.68B | $1.78B | $1.79B | $1.87B | |
| Long-term Debt | · | · | · | · | · | · | · | $1.99B | $1.15B | $1.32B | $1.11B | $1.28B | |
| Total Debt | $2.50B | $2.58B | $2.56B | $2.35B | $1.40B | $1.38B | $1.26B | $2.02B | $1.17B | $1.54B | $1.35B | $1.38B | |
| Common Stock | $22M | $22M | $22M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Paid-in Capital | $1.98B | $1.92B | $1.82B | $1.77B | $1.72B | $1.65B | $1.61B | $1.57B | $1.53B | $1.49B | $1.43B | $1.39B | |
| Retained Earnings | $7.64B | $7.27B | $6.88B | $6.58B | $6.20B | $3.26B | $3.03B | $2.58B | $2.43B | $2.05B | $1.78B | $1.58B | |
| Treasury Stock | $995M | $706M | $710M | $714M | $640M | $617M | $571M | $415M | $415M | $360M | $360M | $295M | |
| AOCI | $-406M | $-422M | $-454M | $-467M | $-341M | $-472M | $-447M | $-431M | $-375M | $-490M | $-192M | $-106M | |
| Stockholders' Equity | $8.24B | $8.08B | $7.55B | $7.17B | $6.94B | $3.82B | $3.63B | $3.31B | $3.18B | $2.70B | $2.67B | $2.57B | |
| Liabilities + Equity | $12.39B | $12.32B | $11.66B | $11.49B | $9.61B | $6.74B | $6.27B | $6.11B | $4.86B | $4.48B | $4.46B | $4.46B | |
| Shares Outstanding | 195,900,000 | 199,600,000 | 198,100,000 | 49,300,000 | 49,300,000 | 49,100,000 | · | · | 48,800,000 | 48,800,000 | 48,300,000 | 48,100,000 |
Cashflow 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $377M | $375M | $368M | $346M | $309M | · | $281M | $275M | $188M | $198M | $191M | $138M | |
| Stock-based Comp | $70M | $75M | $62M | $54M | $44M | $38M | $35M | $43M | $37M | $30M | $33M | $37M | |
| Deferred Tax | $135M | $119M | $45M | $54M | $-2.50B | $-900.0K | $-16M | $3M | $-7M | $-11M | $6M | $-16M | |
| Amort. of Intangibles | $199M | $201M | $186M | $180M | $146M | $137M | $146M | $147M | $68M | $61M | $52M | $36M | |
| Other Non-cash | $-162M | $-252M | $-161M | · | · | · | $-54M | $208M | $2M | $18M | $-42M | $26M | |
| Operating Cash Flow | $796M | $709M | $608M | $692M | $739M | $487M | $713M | $669M | $594M | $510M | $391M | $455M | |
| CapEx | $362M | $421M | $392M | $242M | $214M | $310M | $292M | $194M | $127M | $153M | $243M | $238M | |
| Investing Cash Flow | $-373M | $-765M | $-449M | $-1.83B | $-450M | $-364M | $-351M | $-1.52B | $-381M | $-419M | $-288M | $-1.35B | |
| Debt Issued | $3.11B | $3.52B | $2.12B | $1.51B | $1.43B | $3.20B | $1.14B | $2.75B | $1.41B | $1.58B | $1.20B | $2.56B | |
| Net Debt Issued | $-94M | $17M | $170M | $950M | $12M | $-30M | $-725M | $836M | $49M | $117M | $-171M | $895M | |
| Stock Repurchased | $290M | $0 | $0 | $78M | $25M | $48M | $156M | $0 | $55M | $0 | $67M | $76M | |
| Net Stock Activity | $-290M | $0 | $0 | $-78M | $-25M | $-48M | $-156M | $0 | $-55M | $0 | $-67M | $-76M | |
| Dividends Paid | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Financing Cash Flow | $-426M | $39M | $-174M | $1.19B | $-311M | $-96M | $-351M | $844M | $-228M | $-1M | $-107M | $842M | |
| Net Change in Cash | $3M | $-13M | $-18M | $42M | $-20M | $27M | $9M | $-9M | $-12M | $84M | $-9M | $-52M | |
| Taxes Paid | · | · | · | · | · | · | · | $19M | $16M | $29M | $12M | $16M | |
| Free Cash Flow | $434M | $288M | $215M | $450M | $524M | $176M | $421M | $475M | $466M | $357M | $148M | $217M | |
| Levered FCF | · | · | $140M | $404M | $386M | · | · | $440M | $435M | $333M | $131M | $209M |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% | 63.1% | 66.2% | 64.5% | 63.8% | 59.6% | 59.6% | 63.5% | |
| Operating Margin | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% | 12.8% | 20.6% | 15.9% | 20.1% | 16.5% | 13.2% | 17.8% | |
| Net Margin | 9.2% | 10.1% | 8.2% | 11.7% | 100.8% | 9.8% | 17.6% | 5.5% | 17.4% | 13.9% | 11.3% | 15.7% | |
| Pretax Margin | 13.8% | 14.9% | 11.5% | 14.4% | 16.8% | · | · | 13.1% | 18.4% | 15.0% | 12.0% | 17.3% | |
| EBITDA Margin | 25.9% | 27.8% | 25.1% | 15.3% | 17.3% | 12.8% | 31.2% | 26.8% | 28.9% | 26.6% | 23.8% | 25.9% | |
| ROA | 3.0% | 3.3% | 2.5% | 3.7% | 36.0% | 3.7% | 7.5% | 2.5% | 8.0% | 6.1% | 4.6% | 7.1% | |
| ROE | 4.6% | 5.0% | 4.0% | 5.5% | 54.7% | 6.4% | 13.0% | 4.3% | 12.7% | 10.2% | 7.8% | 10.8% | |
| ROIC | 4.2% | 4.5% | 3.8% | 4.3% | 36.3% | · | · | 3.2% | 9.3% | 7.1% | 5.6% | 7.1% |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.9 | 1.9 | 1.8 | 1.2 | 2.0 | 1.3 | 1.0 | 2.0 | 2.4 | 1.7 | 1.5 | 1.8 | |
| Quick Ratio | 0.8 | 0.8 | 0.8 | 0.5 | 0.8 | 0.5 | 0.5 | 0.8 | 1.0 | 0.7 | 0.5 | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.6 | 0.4 | 0.6 | 0.5 | 0.5 | |
| LT Debt / Equity | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.6 | 0.4 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | 5.1 | 8.9 | 21.9 | 8.5 | 8.0 | 4.9 | 12.8 | 12.4 | 13.1 | 38.5 |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.4 | 0.4 | 0.5 | 0.5 | 0.4 | 0.4 | 0.5 | |
| Inventory Turnover | 1.7 | 1.7 | 1.8 | 1.9 | 1.7 | 1.7 | 1.8 | 2.0 | 1.8 | 1.9 | 1.8 | 1.7 | |
| Receivables Turnover | 5.3 | 5.9 | 6.2 | 6.2 | 6.1 | 5.6 | 6.6 | 7.3 | 7.0 | 6.8 | 6.4 | 6.8 |
Wachstumsraten 9
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 5.1% | 8.4% | 8.6% | 13.2% | 20.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 7.3% | 10.1% | 13.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -4.6% | 32.4% | -23.7% | -96.7% | 1129.9% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -1.2% | -67.9% | -32.5% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -17.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -4.4% | 33.3% | -23.7% | -86.9% | 1135.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -0.95% | -48.9% | 7.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 9.5% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 17
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B | $2.43B | $2.65B | $2.53B | $2.14B | $1.97B | $1.80B | $1.72B | |
| Net Income TTM | $375M | $392M | $294M | $386M | $2.94B | $238M | $467M | $140M | $373M | $274M | $204M | $270M | |
| Market Cap | $13.70B | $20.89B | $3.86B | $3.37B | $5.14B | · | · | · | $2.93B | $2.15B | $1.84B | $1.97B | |
| Enterprise Value | $16.09B | $23.37B | $6.30B | $5.58B | $6.44B | · | · | · | $4.02B | $3.59B | $3.18B | $3.33B | |
| P/E | 37.4 | 53.4 | 52.7 | 35.2 | 1.8 | 16.6 | 7.8 | 23.0 | 8.0 | 7.9 | 9.2 | 7.4 | |
| P/S | 3.3 | 5.4 | 1.1 | 1.0 | 1.8 | · | · | · | 1.4 | 1.1 | 1.0 | 1.1 | |
| P/B | 1.7 | 2.6 | 0.5 | 0.5 | 0.7 | · | · | · | 0.9 | 0.8 | 0.7 | 0.8 | |
| P / Tangible Book | 4.9 | 8.5 | 1.7 | 2.0 | 1.7 | · | · | · | · | · | · | · | |
| P / Cash Flow | 17.2 | 29.5 | 6.4 | 4.9 | 7.0 | · | · | · | 4.9 | 4.2 | 4.7 | 4.3 | |
| P / FCF | 31.6 | 72.5 | 17.9 | 7.5 | 9.8 | · | · | · | 6.3 | 6.0 | 12.4 | 9.1 | |
| EV / EBITDA | 15.2 | 21.6 | 7.0 | 11.0 | 12.7 | · | · | · | 6.5 | 6.9 | 7.4 | 7.5 | |
| EV / FCF | 37.1 | 81.1 | 29.3 | 12.4 | 12.3 | · | · | · | 8.6 | 10.1 | 21.5 | 15.4 | |
| EV / Revenue | 3.9 | 6.0 | 1.8 | 1.7 | 2.2 | · | · | · | 1.9 | 1.8 | 1.8 | 1.9 | |
| Dividend Yield | 0.00% | 0.00% | 0.08% | 0.09% | 0.06% | · | · | · | 0.10% | 0.14% | 0.16% | 0.15% | |
| Earnings Yield | 2.7% | 1.9% | 1.9% | 2.8% | 56.8% | 6.0% | 12.8% | 4.3% | 12.5% | 12.7% | 10.9% | 13.5% | |
| Payout Ratio | 0.00% | 0.00% | 1.0% | 0.78% | 0.10% | 1.3% | 0.64% | 2.1% | 0.78% | 1.1% | 1.4% | 1.1% | |
| Annual Payout | $0 | $0 | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.08B | $1.02B | $1.07B | $1.06B | $1.00B | $965M | $1.02B | $1.00B | $943M | $932M | $927M | $930M | $877M | $858M | $848M | $843M | |
| Cost of Revenue | $346M | $329M | $414M | $368M | $323M | $304M | $341M | $340M | $311M | $308M | $321M | $320M | $294M | $300M | $311M | $291M | |
| Gross Profit | $735M | $695M | $651M | $692M | $679M | $660M | $678M | $663M | $631M | $624M | $606M | $610M | $583M | $558M | $537M | $552M | |
| R&D Expense | $42M | $44M | $41M | $45M | $46M | $41M | $38M | $39M | $39M | $40M | $37M | $36M | $33M | $32M | $29M | $29M | |
| SG&A Expense | $676M | $390M | $419M | $422M | $399M | $388M | $391M | $381M | $380M | $381M | $388M | $375M | $408M | $331M | $358M | $343M | |
| Operating Income | $-31M | $213M | $140M | $176M | $185M | $182M | $198M | $192M | $162M | $153M | $136M | $152M | $96M | $150M | $104M | $141M | |
| Interest Expense | · | · | · | · | · | · | · | · | $29M | $30M | · | $27M | $26M | $26M | · | $17M | |
| Other Non-op | $4M | $2M | $800.0K | $2M | $-16M | $-3M | $-3M | $-300.0K | $-3M | $-3M | $-3M | $-6M | $-5M | $-1M | $-8M | $-6M | |
| Pretax Income | $-48M | $192M | $117M | $152M | $144M | $153M | $169M | $164M | $130M | $120M | $106M | $119M | $66M | $122M | $72M | $117M | |
| Income Tax | $30M | $61M | $32M | $54M | $57M | $49M | $51M | $59M | $41M | $39M | $22M | $34M | $26M | $38M | $7M | $19M | |
| Net Income | $-78M | $131M | $85M | $98M | $88M | $104M | $118M | $105M | $89M | $81M | $84M | $85M | $40M | $85M | $66M | $98M | |
| EPS (Basic) | $-0.40 | $0.67 | $0.43 | $0.49 | $0.44 | $0.52 | $0.58 | $0.53 | $0.45 | $0.41 | $0.43 | $0.43 | $0.20 | $0.43 | $-4.54 | $1.99 | |
| EPS (Diluted) | $-0.40 | $0.66 | $0.42 | $0.49 | $0.44 | $0.52 | $0.59 | $0.52 | $0.44 | $0.41 | $0.42 | $0.43 | $0.20 | $0.43 | $-4.50 | $1.98 | |
| Shares (Basic) | 195,000,000 | 195,800,000 | -399,800,000 | 199,300,000 | 199,900,000 | 199,700,000 | -397,500,000 | 199,100,000 | 198,900,000 | 198,400,000 | -395,600,000 | 198,100,000 | 197,900,000 | 197,500,000 | 49,400,000 | 49,300,000 | |
| Shares (Diluted) | 195,000,000 | 196,700,000 | -401,900,000 | 200,000,000 | 200,700,000 | 201,200,000 | -400,600,000 | 200,600,000 | 200,500,000 | 199,900,000 | -398,200,000 | 199,600,000 | 199,200,000 | 198,700,000 | 49,600,000 | 49,600,000 | |
| EBITDA | $-31M | $308M | · | $176M | $185M | $273M | · | $192M | $162M | $250M | · | $152M | $96M | $239M | · | $141M |
Bilanz 28
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $139M | $125M | $111M | $125M | $116M | $101M | $108M | $110M | $112M | $135M | $121M | $117M | $112M | $118M | $138M | $246M | |
| Receivables | $809M | $807M | $829M | $792M | $781M | $716M | $717M | $739M | $689M | $651M | · | $630M | $565M | $582M | · | $544M | |
| Inventory | $896M | $876M | $846M | $881M | $880M | $843M | $803M | $779M | $775M | $748M | · | $724M | $699M | $659M | · | $622M | |
| Prepaid Expense | $455M | $325M | $321M | $340M | $348M | $327M | $324M | $299M | $282M | $260M | · | $240M | $224M | $218M | · | $186M | |
| Current Assets | $2.30B | $2.13B | $2.11B | $2.14B | $2.13B | $1.99B | $1.95B | $1.93B | $1.86B | $1.79B | · | $1.71B | $1.60B | $1.58B | · | $1.60B | |
| PP&E (Net) | · | · | $2.08B | · | · | · | $1.86B | $1.75B | $1.71B | $1.68B | · | $1.53B | $1.49B | $1.46B | · | $1.36B | |
| PP&E (Gross) | · | · | $3.91B | · | · | · | $3.56B | · | · | · | · | · | · | · | · | $2.75B | |
| Accum. Depreciation | · | · | $1.83B | · | · | · | $1.70B | · | · | · | · | · | · | · | · | $1.38B | |
| Goodwill | $3.89B | $3.91B | $3.85B | $3.86B | $3.86B | $3.79B | $3.84B | $3.78B | $3.76B | $3.77B | · | $3.68B | $3.66B | $3.67B | · | $3.67B | |
| Intangibles | $1.49B | $1.54B | $1.59B | $1.64B | $1.69B | $1.74B | $1.79B | $1.79B | $1.80B | $1.85B | · | $1.77B | $1.81B | $1.86B | · | $1.92B | |
| Other Non-current Assets | $673M | $688M | $689M | $653M | $659M | $664M | $661M | $621M | $637M | $617M | · | $628M | $585M | $569M | · | $306M | |
| Total Assets | $12.48B | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | $11.66B | $11.70B | $11.54B | $11.56B | $11.49B | $11.55B | |
| Accounts Payable | $233M | $226M | $300M | $256M | $244M | $202M | $260M | $222M | $231M | $202M | · | $227M | $242M | $224M | · | $227M | |
| Short-term Debt | $598M | $620M | $47M | $46M | $59M | $48M | $32M | $40M | $41M | $45M | · | $63M | $58M | $52M | · | $535M | |
| Current Liabilities | $1.80B | $1.60B | $1.11B | $1.01B | $1.01B | $1000M | $1.02B | $970M | $952M | $965M | · | $994M | $949M | $916M | · | $1.38B | |
| Capital Leases | · | · | $240M | · | · | · | $231M | · | · | · | · | · | · | · | · | $216M | |
| Deferred Tax | $96M | $96M | $93M | $102M | $99M | $95M | $96M | $95M | $94M | $90M | · | $138M | $139M | $144M | · | $144M | |
| Other Non-current Liabilities | $266M | $277M | $283M | $263M | $274M | $261M | $312M | $277M | $278M | $281M | · | · | · | · | · | · | |
| Total Liabilities | $4.24B | $4.06B | $4.16B | $4.02B | $4.13B | $4.09B | $4.23B | $4.18B | $4.24B | $4.34B | · | $4.17B | $4.16B | $4.23B | · | $4.47B | |
| Total Debt | $2.46B | $2.50B | · | $2.48B | $2.58B | $2.54B | · | $2.63B | $2.71B | $2.77B | · | $2.57B | $2.62B | $2.68B | · | $2.88B | |
| Common Stock | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | $22M | · | $5M | $5M | $5M | · | $5M | |
| Paid-in Capital | $1.98B | $1.99B | $1.98B | $1.96B | $1.94B | $1.93B | $1.92B | $1.88B | $1.87B | $1.85B | · | $1.82B | $1.80B | $1.78B | · | $1.75B | |
| Retained Earnings | $7.70B | $7.77B | $7.64B | $7.56B | $7.46B | $7.37B | $7.27B | $7.15B | $7.05B | $6.96B | · | $6.79B | $6.71B | $6.67B | · | $6.52B | |
| Treasury Stock | $1.10B | $1.09B | $995M | $796M | $745M | $705M | $706M | $707M | $708M | $709M | · | $711M | $712M | $713M | · | $716M | |
| AOCI | $-363M | $-334M | $-406M | $-392M | $-392M | $-490M | $-422M | $-425M | $-423M | $-422M | · | $-375M | $-424M | $-404M | · | $-477M | |
| Stockholders' Equity | $8.24B | $8.36B | $8.24B | $8.35B | $8.29B | $8.13B | $8.08B | $7.92B | $7.80B | $7.70B | · | $7.53B | $7.38B | $7.34B | · | $7.08B | |
| Liabilities + Equity | $12.48B | $12.42B | $12.39B | $12.38B | $12.41B | $12.22B | $12.32B | $12.11B | $12.05B | $12.03B | · | $11.70B | $11.54B | $11.56B | · | $11.55B | |
| Shares Outstanding | 194,900,000 | 195,100,000 | 195,900,000 | 198,800,000 | 199,500,000 | 199,900,000 | 199,600,000 | 199,100,000 | 199,100,000 | 198,700,000 | · | 49,500,000 | 49,500,000 | 49,400,000 | · | 49,300,000 |
Cashflow 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $95M | $96M | $98M | $95M | $93M | $91M | $91M | $89M | $98M | $97M | $93M | $94M | $91M | $90M | $89M | $82M | |
| Deferred Tax | $44M | $44M | $13M | $44M | $44M | $35M | $22M | $36M | $32M | $29M | · | · | · | · | $-1M | $19M | |
| Amort. of Intangibles | $48M | $48M | $50M | $50M | $50M | $50M | $50M | $50M | $50M | $50M | $46M | $47M | $46M | $46M | $46M | $40M | |
| Other Non-cash | · | $-45M | · | · | · | $-115M | · | · | · | $-165M | · | · | · | $-36M | · | · | |
| Operating Cash Flow | $183M | $261M | $248M | $261M | $96M | $191M | $268M | $208M | $111M | $123M | $174M | $142M | $124M | $167M | $131M | $264M | |
| CapEx | $86M | $102M | $98M | $97M | $78M | $89M | $140M | $89M | $74M | $118M | $145M | $91M | $74M | $83M | $95M | $47M | |
| Investing Cash Flow | $-90M | $-103M | $-99M | $-98M | $-79M | $-97M | $-242M | $-124M | $-75M | $-324M | $-161M | $-93M | $-82M | $-113M | $-100M | $-46M | |
| Debt Issued | $858M | $875M | $936M | $756M | $749M | $670M | $716M | $1.40B | $608M | $795M | $472M | $453M | $497M | $702M | $12M | $-4M | |
| Net Debt Issued | · | $-29M | · | · | · | $-59M | · | · | · | $202M | · | · | · | $276M | · | · | |
| Stock Repurchased | $16M | $92M | $197M | $53M | $41M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | $-92M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Dividends Paid | · | · | · | · | · | · | $0 | $0 | · | · | $2M | $0 | · | · | $2M | $0 | |
| Financing Cash Flow | $-76M | $-148M | $-164M | $-156M | $-9M | $-97M | $-28M | $-88M | $-57M | $212M | $-6M | $-43M | $-47M | $-78M | $-134M | $-369M | |
| Net Change in Cash | $14M | $14M | $-14M | $9M | $15M | $-7M | $-2M | $-3M | $-23M | $14M | $3M | $5M | $-6M | $-20M | $-108M | $-153M | |
| Free Cash Flow | · | $159M | · | · | · | $101M | · | · | · | $5M | · | · | · | $84M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-16M | · | · | · | $66M | · | · |
Rentabilität 8
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.0% | 67.9% | · | 65.3% | 67.8% | 68.4% | · | 66.1% | 67.0% | 67.0% | · | 65.6% | 66.4% | 65.1% | · | 65.5% | |
| Operating Margin | -2.9% | 20.8% | · | 16.6% | 18.4% | 18.9% | · | 19.2% | 17.2% | 16.4% | · | 16.3% | 11.0% | 17.4% | · | 16.7% | |
| Net Margin | -7.2% | 12.8% | · | 9.3% | 8.8% | 10.8% | · | 10.4% | 9.4% | 8.7% | · | 9.2% | 4.5% | 9.8% | · | 11.7% | |
| Pretax Margin | -4.5% | 18.8% | · | 14.3% | 14.4% | 15.9% | · | 16.3% | 13.8% | 12.9% | · | 12.8% | 7.5% | 14.2% | · | 13.9% | |
| EBITDA Margin | -2.9% | 30.1% | · | 16.6% | 18.4% | 28.3% | · | 19.2% | 17.2% | 26.8% | · | 16.3% | 11.0% | 27.9% | · | 16.7% | |
| ROA | -0.63% | 1.1% | · | 0.80% | 0.72% | 0.86% | · | 0.88% | 0.75% | 0.69% | · | 0.73% | 0.34% | 0.73% | · | 0.93% | |
| ROE | -0.94% | 1.6% | · | 1.2% | 1.1% | 1.3% | · | 1.4% | 1.2% | 1.1% | · | 1.2% | 0.55% | 1.2% | · | 1.4% | |
| ROIC | -0.47% | 1.3% | · | 1.1% | 1.0% | 1.2% | · | 1.2% | 1.1% | 0.99% | · | 1.1% | 0.58% | 1.0% | · | 1.2% |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | · | 2.1 | 2.1 | 2.0 | · | 2.0 | 2.0 | 1.9 | · | 1.7 | 1.7 | 1.7 | · | 1.2 | |
| Quick Ratio | 0.5 | 0.6 | · | 0.9 | 0.9 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.7 | 0.8 | · | 0.6 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.4 | 0.4 | · | 0.4 | |
| LT Debt / Equity | 0.2 | 0.2 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | 5.6 | 5.1 | · | 5.7 | 3.7 | 5.7 | · | 8.2 |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.5 | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | |
| Receivables Turnover | 1.4 | 1.3 | · | 1.4 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.6 | 1.6 | 1.6 | · | 1.6 |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.17B | $4.05B | · | $4.03B | $3.91B | $3.84B | · | $3.81B | $3.68B | $3.60B | · | $3.51B | $3.41B | $3.32B | · | $3.22B | |
| Net Income TTM | $239M | $421M | · | $395M | $386M | $379M | · | $360M | $295M | $291M | · | $308M | $349M | $405M | · | $936M | |
| Market Cap | $12.26B | $15.81B | · | $14.05B | $16.29B | $19.30B | · | $18.58B | $17.73B | $18.53B | · | $4.84B | $4.72B | $4.31B | · | $4.03B | |
| Enterprise Value | $14.58B | $18.18B | · | $16.40B | $18.76B | $21.74B | · | $21.10B | $20.33B | $21.16B | · | $7.30B | $7.23B | $6.87B | · | $6.67B | |
| P/E | 52.9 | 38.4 | · | 35.9 | 42.5 | 51.1 | · | 51.9 | 60.2 | 63.4 | · | 32.2 | 18.5 | 12.7 | · | 4.3 | |
| P/S | 2.9 | 3.9 | · | 3.5 | 4.2 | 5.0 | · | 4.9 | 4.8 | 5.2 | · | 1.4 | 1.4 | 1.3 | · | 1.3 | |
| P/B | 1.5 | 1.9 | · | 1.7 | 2.0 | 2.4 | · | 2.3 | 2.3 | 2.4 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| P / Tangible Book | 4.3 | 5.4 | · | 4.9 | 6.0 | 7.4 | · | 7.9 | 7.9 | 8.9 | · | 2.3 | 2.5 | 2.4 | · | 2.7 | |
| P / Cash Flow | · | 60.6 | · | · | · | 101.3 | · | · | · | 151.0 | · | · | · | 25.9 | · | · | |
| P / FCF | · | 99.6 | · | · | · | 190.7 | · | · | · | 4028.3 | · | · | · | 51.5 | · | · | |
| EV / EBITDA | -470.3 | 59.0 | · | 93.4 | 101.5 | 79.6 | · | 109.6 | 125.7 | 84.7 | · | 48.1 | 75.1 | 28.7 | · | 47.4 | |
| EV / FCF | · | 114.6 | · | · | · | 214.8 | · | · | · | 4600.7 | · | · | · | 82.1 | · | · | |
| EV / Revenue | 3.5 | 4.5 | · | 4.1 | 4.8 | 5.7 | · | 5.5 | 5.5 | 5.9 | · | 2.1 | 2.1 | 2.1 | · | 2.1 | |
| Earnings Yield | 1.9% | 2.6% | · | 2.8% | 2.4% | 2.0% | · | 1.9% | 1.7% | 1.6% | · | 3.1% | 5.4% | 7.9% | · | 23.0% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| Umsatz | $4.09B | $3.90B | $3.59B | $3.31B | $2.92B |
| Bruttogewinnmarge % | 65.5% | 66.6% | 65.6% | 64.7% | 66.9% |
| Betriebsgewinnmarge % | 16.7% | 18.1% | 14.8% | 15.3% | 17.3% |
| Nettoergebnis | $375M | $392M | $294M | $386M | $2.94B |
| Verwässerte EPS | $1.87 | $1.96 | $1.48 | $1.94 | $59.16 |
Bilanz
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.3 | 0.3 | 0.3 | 0.3 | 0.2 |
| Liquiditätsgrad | 1.9 | 1.9 | 1.8 | 1.2 | 2.0 |
| Quick Ratio | 0.8 | 0.8 | 0.8 | 0.5 | 0.8 |
Cashflow
| 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $434M | $288M | $215M | $450M | $524M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Handelssignale Aktuelle Kauf-/Verkaufssignale mit Einstiegspreis und Risiko-Ertrags-Verhältnis
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 744 Einreicher · $9.7B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 118 (+10 vs. Vorquartal) | 94 (+10 vs. Vorquartal) | 244 (+11 vs. Vorquartal) | 233 (-4 vs. Vorquartal) | +36.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $914.931.325 | 12.758.769 | 9,43% | Aktien |
| STATE STREET CORP | $637.691.430 | 8.892.643 | 6,57% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $621.703.470 | 8.669.690 | 6,41% | Aktien |
| BROWNING WEST LP | $515.984.142 | 7.195.428 | 5,32% | Aktien |
| GENERATION INVESTMENT MANAGEMENT LLP | $356.303.541 | 4.968.673 | 3,67% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $337.031.684 | 4.720.661 | 3,47% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $287.152.440 | 4.004.357 | 2,96% | Aktien |
| Longview Partners (Guernsey) LTD | $282.537.902 | 3.940.007 | 2,91% | Aktien |
| CITADEL ADVISORS LLC | $277.086.436 | 3.863.986 | 2,86% | Aktien |
| JANA Partners Management, LP | $256.899.641 | 3.582.480 | 2,65% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $214.288.268 | 2.988.262 | 2,21% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $211.804.736 | 2.953.629 | 2,18% | Aktien |
| LONDON CO OF VIRGINIA | $207.821.082 | 2.898.075 | 2,14% | Aktien |
| Diamond Hill Capital Management, LLC (Investment Advisor) | $195.854.209 | 2.731.198 | 2,02% | Aktien |
| River Road Asset Management, LLC | $142.048.546 | 1.980.875 | 1,46% | Aktien |
| Sustainable Growth Advisers, LP | $139.368.026 | 1.943.495 | 1,44% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $132.231.017 | 1.843.969 | 1,36% | Aktien |
| Gates Capital Management, Inc. | $121.088.717 | 1.688.589 | 1,25% | Aktien |
| Alecta Tjanstepension Omsesidigt | $112.082.730 | 1.563.000 | 1,16% | Aktien |
| BARCLAYS PLC | $108.118.888 | 1.507.724 | 1,11% | Aktien |
| MANNING & NAPIER ADVISORS LLC | $107.938.609 | 1.505.210 | 1,11% | Aktien |
| Focus Partners Wealth | $101.143.265 | 1.410.461 | 1,04% | Aktien |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $100.125.518 | 1.396.256 | 1,03% | Aktien |
| Findlay Park Partners LLP | $92.075.640 | 1.284.000 | 0,95% | Aktien |
| BANK OF AMERICA CORP /DE/ | $85.233.287 | 1.188.583 | 0,88% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $78.580.965 | 1.095.816 | 0,81% | Aktien |
| Holocene Advisors, LP | $77.495.348 | 1.080.677 | 0,80% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $72.342.127 | 1.011.778 | 0,75% | Aktien |
| Balyasny Asset Management L.P. | $71.022.946 | 990.419 | 0,73% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $69.128.942 | 964.007 | 0,71% | Aktien |
| ENVESTNET ASSET MANAGEMENT INC | $63.808.602 | 889.815 | 0,66% | Aktien |
| STOREBRAND ASSET MANAGEMENT AS | $56.153.519 | 783.064 | 0,58% | Aktien |
| HARRIS ASSOCIATES L P | $54.967.149 | 766.520 | 0,57% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $52.710.220 | 735.047 | 0,54% | Aktien |
| NORGES BANK | $52.378.920 | 730.427 | 0,54% | Aktien |
| Quantinno Capital Management LP | $47.268.411 | 659.160 | 0,49% | Aktien |
| DAVENPORT & Co LLC | $44.161.791 | 617.390 | 0,46% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $43.870.959 | 611.783 | 0,45% | Aktien |
| Capital World Investors | $42.389.789 | 591.128 | 0,44% | Aktien |
| TD Asset Management Inc | $40.340.389 | 562.549 | 0,42% | Aktien |
| GOLDMAN SACHS GROUP INC | $39.475.710 | 550.491 | 0,41% | Aktien |
| Swiss National Bank | $39.462.013 | 550.300 | 0,41% | Aktien |
| FMR LLC | $38.283.244 | 533.862 | 0,39% | Aktien |
| Assenagon Asset Management S.A. | $37.710.281 | 525.872 | 0,39% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $36.228.466 | 505.208 | 0,37% | Aktien |
| VANGUARD GROUP INC | $35.623.996 | 434.651 | 0,37% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $34.958.672 | 492.237 | 0,36% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $34.732.165 | 484.342 | 0,36% | Aktien |
| Sumitomo Mitsui Trust Group, Inc. | $31.878.681 | 444.550 | 0,33% | Aktien |
| CRAMER ROSENTHAL MCGLYNN LLC | $31.864.984 | 444.359 | 0,33% | Aktien |
| HBK INVESTMENTS L P | $31.666.377 | 441.651 | 0,33% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $31.217.873 | 435.335 | 0,32% | Aktien |
| Champlain Investment Partners, LLC | $30.908.803 | 431.025 | 0,32% | Aktien |
| BAMCO INC /NY/ | $30.683.848 | 427.888 | 0,32% | Aktien |
| Vanguard Global Advisers, LLC | $30.491.881 | 425.211 | 0,31% | Aktien |
| CI INVESTMENTS INC. | $30.192.492 | 421.036 | 0,31% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $30.114.830 | 419.953 | 0,31% | Aktien |
| Rathbones Group PLC | $29.369.475 | 409.559 | 0,30% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $28.555.137 | 398.203 | 0,29% | Aktien |
| BlackRock, Inc. | $27.878.553 | 388.768 | 0,29% | Aktien |
| Sone Capital Management, LLC | $27.753.921 | 387.030 | 0,29% | Aktien |
| RHUMBLINE ADVISERS | $27.647.083 | 385.541 | 0,28% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $27.579.164 | 384.593 | 0,28% | Aktien |
| UBS Group AG | $24.922.811 | 347.550 | 0,26% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $24.912.915 | 347.412 | 0,26% | Aktien |
| WESTWOOD HOLDINGS GROUP INC | $24.817.325 | 346.079 | 0,26% | Aktien |
| Gotham Asset Management, LLC | $24.697.067 | 344.402 | 0,25% | Aktien |
| California Public Employees Retirement System | $24.485.810 | 341.456 | 0,25% | Aktien |
| ASSETMARK, INC | $23.939.488 | 333.838 | 0,25% | Aktien |
| NOMURA HOLDINGS INC | $22.887.824 | 319.172 | 0,24% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $22.435.556 | 313.784 | 0,23% | Aktien |
| Woodline Partners LP | $21.808.875 | 304.126 | 0,22% | Aktien |
| Triodos Investment Management BV | $21.477.145 | 299.500 | 0,22% | Aktien |
| FIRST TRUST ADVISORS LP | $20.079.166 | 280.006 | 0,21% | Aktien |
| Trajan Wealth LLC | $19.347.573 | 269.803 | 0,20% | Aktien |
| Ruffer LLP | $19.239.619 | 268.591 | 0,20% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $18.969.088 | 264.525 | 0,20% | Aktien |
| MARSHALL WACE, LLP | $18.353.386 | 255.939 | 0,19% | Aktien |
| Estuary Capital Management LP | $18.092.433 | 252.300 | 0,19% | Aktien |
| Eurizon Capital SGR S.p.A. | $17.361.572 | 242.170 | 0,18% | Aktien |
| HSBC HOLDINGS PLC | $17.306.086 | 241.368 | 0,18% | Aktien |
| Boston Trust Walden Corp | $16.741.417 | 233.460 | 0,17% | Aktien |
| OSSIAM | $16.681.180 | 232.620 | 0,17% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $16.202.875 | 225.950 | 0,17% | Aktien |
| TAURUS ASSET MANAGEMENT, LLC | $16.182.885 | 191.854 | 0,17% | Aktien |
| Soapstone Management L.P. | $16.134.750 | 225.000 | 0,17% | Aktien |
| ROYCE & ASSOCIATES LP | $16.054.363 | 223.879 | 0,17% | Aktien |
| PFM Health Sciences, LP | $15.840.022 | 220.890 | 0,16% | Aktien |
| SHAPIRO CAPITAL MANAGEMENT LLC | $15.087.784 | 210.400 | 0,16% | Aktien |
| STIFEL FINANCIAL CORP | $14.726.022 | 205.355 | 0,15% | Aktien |
| HEARTLAND ADVISORS INC | $14.616.936 | 203.834 | 0,15% | Aktien |
| CIBC WORLD MARKETS CORP | $14.560.604 | 177.655 | 0,15% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $14.355.484 | 200.776 | 0,15% | Aktien |
| Bellevue Group AG | $14.136.551 | 197.135 | 0,15% | Aktien |
| Point72 (DIFC) Ltd | $14.092.165 | 205.545 | 0,15% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $14.090.298 | 196.490 | 0,15% | Aktien |
| BROWN ADVISORY INC | $13.759.715 | 191.880 | 0,14% | Aktien |
| SEB Asset Management AB | $13.427.318 | 187.245 | 0,14% | Aktien |
| Legal & General Group Plc | $13.292.093 | 185.359 | 0,14% | Aktien |
| Engineers Gate Manager LP | $13.281.481 | 185.211 | 0,14% | Aktien |
Unternehmensinsider 45 Insider · 22 Führungskräfte · 17 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| REMMELL PAUL L | Pres & CEO - CooperSurgical | 14. Juli 2017 M | 1.352 | 0 | 0 | $0 |
| Nicholas J Pichotta | Pres, CEO Cooper Medical, Inc. | 8. Januar 2014 M | 10.697 | 0 | 0 | $0 |
| Brian G Andrews | SVP, CFO & Treasurer | 25. März 2019 S | 1.101 | 0 | 0 | $0 |
| Gregory W Matz | SVP, CFO & CRO | 13. Juni 2016 M | 15.123 | 0 | 0 | $0 |
| Steven M Neil | EVP & CFO | 16. Januar 2008 P | 4.300 | 0 | 0 | $0 |
| John J Calcagno | CFO - CooperVision | 25. Oktober 2007 A | 0 | 0 | 0 | $0 |
| Robert D Auerbach | President, CSI | 1. April 2019 M | 2.538 | 0 | 0 | $0 |
| John Arthur Weber | President, CooperVision, Inc. | 8. Januar 2014 M | 15.260 | 0 | 0 | $0 |
| Dennis Murphy | President Americas, CVI | 11. September 2009 M | 0 | 0 | 0 | $0 |
| Gregory A Fryling | Pres & COO - CVI | 24. Oktober 2006 A | 3.790 | 0 | 0 | $0 |
| Agostino Ricupati | SVP & CAO | 1. April 2024 M | 4.818 | 0 | 0 | $0 |
| Randal Golden | VP, General Counsel & Sec. | 19. Juni 2019 S | 1.148 | 0 | 0 | $0 |
| Holly R Sheffield | EVP, CSO | 11. Dezember 2018 A | — | 0 | 0 | $0 |
| Carol R Kaufman | EVP, Sec. & Chief Gov. Officer | 11. April 2018 G | 45.898 | 0 | 0 | $0 |
| Tina Maloney | VP, Corporate Controller | 8. Januar 2017 M | 2.874 | 0 | 0 | $0 |
| Rodney Folden | VP & Corporate Controller | 8. Januar 2014 M | 8.592 | 0 | 0 | $0 |
| Eugene J Midlock | VP Tax | 9. Januar 2012 M | 2.137 | 0 | 0 | $0 |
| Jeffrey Alan Mclean | Exec VP, Comm. Strategies-CVI | 11. Dezember 2008 A | 0 | 0 | 0 | $0 |
| Christopher J Marmo | VP, R&D of CooperVision, Inc. | 24. Oktober 2006 A | — | 0 | 0 | $0 |
| Norris B Battin | VP, Investor Relations | 24. Oktober 2006 A | 4.000 | 0 | 0 | $0 |
| David Acosta | Treasurer | 8. April 2005 S | 10.000 | 0 | 0 | $0 |
| Stephen Whiteford | VP, Corporate Controller | 20. Januar 2004 M | 15.052 | 0 | 0 | $0 |
| Keel Paul A | Direktor | 1. Juli 2026 A | — | 0 | 0 | $0 |
| Robert S Weiss | Direktor | 1. April 2026 A | 292.599 | 0 | 0 | $0 |
| MADDEN TERESA S | Direktor | 1. April 2026 A | 15.679 | 0 | 0 | $0 |
| Allan E Rubenstein | Direktor | 12. September 2019 S | 3.091 | 0 | 0 | $0 |
| Jody S Lindell | Direktor | 24. Juni 2019 M | 12.554 | 0 | 0 | $0 |
| Gary S Petersmeyer | Direktor | 17. Juni 2019 S | 1.588 | 0 | 0 | $0 |
| Michael Kalkstein | Direktor | 6. Juni 2019 M | 6.338 | 0 | 0 | $0 |
| Colleen Jay | Direktor | 21. Mai 2019 A | 3.658 | 0 | 0 | $0 |
| William A Kozy | Direktor | 21. Mai 2019 A | 3.928 | 0 | 0 | $0 |
| Thomas A Bender | Direktor | 21. Mai 2019 A | 12.952 | 0 | 0 | $0 |
| Stanley Zinberg MD | Direktor | 12. März 2019 M | 10.528 | 0 | 0 | $0 |
| Steven Rosenberg | Direktor | 5. Januar 2016 A | 12.359 | 0 | 0 | $0 |
| Donald Press | Direktor | 7. Januar 2014 A | 43.970 | 0 | 0 | $0 |
| Moses Marx | Direktor | 1. Dezember 2009 A | 107.532 | 0 | 0 | $0 |
| FRUTH JOHN D | Direktor | 14. Januar 2008 A | 6.500 | 0 | 0 | $0 |
| Edgar J Cummins | Direktor | 27. Dezember 2005 S | 1.764 | 0 | 0 | $0 |
| COOPER COMPANIES INC | Direktor | 1. November 2004 A | — | 0 | 0 | $0 |
| Lawrence E. Kurzius | — | 1. April 2026 A | 11.099 | 2 | 0 | $301.780 |
| Cynthia L Lucchese | — | 1. April 2026 A | 12.767 | 1 | 0 | $149.963 |
| Daniel G Mcbride | — | 8. Januar 2026 M | 69.352 | 0 | 0 | $0 |
| Albert G White III | — | 10. Dezember 2024 A | 245.072 | 1 | 0 | $808.000 |
| Andrew Sedgwick | — | 30. September 2009 M | 0 | 0 | 0 | $0 |
| James M Welch | — | 27. Oktober 2005 A | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 143 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2,53% | 17.664 NS | 30. April 2026 | N-PORT |
| POWA · Invesco Exchange-Traded Self-Indexe… | 2,24% | 55.341 SH | 8. August 2026 | Täglich |
| EQTY · Valued Advisers Trust | 1,94% | 404.353 NS | 30. April 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,66% | 175.209 SH | 8. August 2026 | Täglich |
| TMFM · RBB Fund, Inc. | 1,54% | 29.422 NS | 31. Mai 2026 | N-PORT |
| CSMD · Professionally Managed Portfolios | 1,25% | 85.861 NS | 30. April 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,14% | 158.790 NS | 30. April 2026 | N-PORT |
| NUMV · Nushares ETF Trust | 1,02% | 69.990 NS | 30. April 2026 | N-PORT |
| BSMQ · Invesco Exchange-Traded Self-Indexe… | 0,70% | 1.880.000 | 8. August 2026 | Täglich |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0,70% | 111.300 SH | 8. August 2026 | Täglich |
| CGMM · Capital Group Equity ETF Trust I | 0,36% | 164.570 NS | 31. Mai 2026 | N-PORT |
| FTA · First Trust Exchange-Traded AlphaDE… | 0,31% | 63.124 NS | 30. April 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,30% | 2.841.101 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,27% | 25.490 SH | 8. August 2026 | Täglich |
| IYH · iShares Trust | 0,23% | 116.753 SH | 8. August 2026 | Täglich |
| SIZE · iShares Trust | 0,23% | 13.474 SH | 8. August 2026 | Täglich |
| SCHM · SCHWAB STRATEGIC TRUST | 0,22% | 530.369 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,22% | 8.750 SH | 8. August 2026 | Täglich |
| BSMU · Invesco Exchange-Traded Self-Indexe… | 0,21% | 545.000 | 8. August 2026 | Täglich |
| EVUS · iShares Trust | 0,21% | 10.920 SH | 8. August 2026 | Täglich |
| EUSA · iShares, Inc. | 0,21% | 55.200 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,21% | 586.725 SH | 8. August 2026 | Täglich |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 2.739.985 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,20% | 90.338 NS | 30. April 2026 | N-PORT |
| ISCG · iShares Trust | 0,18% | 24.891 SH | 8. August 2026 | Täglich |
| IXJ · iShares Trust | 0,18% | 102.346 SH | 8. August 2026 | Täglich |
| CURE · Direxion Shares ETF Trust | 0,18% | 3.907 NS | 30. April 2026 | N-PORT |
| RXL · ProShares Trust | 0,17% | 2.044 NS | 31. Mai 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,17% | 4.474.789 SH | 8. August 2026 | Täglich |
| NBCR · Neuberger Berman ETF Trust | 0,16% | 23.148 NS | 31. Mai 2026 | N-PORT |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,15% | 3.340 NS | 30. April 2026 | N-PORT |
| FEX · First Trust Exchange-Traded AlphaDE… | 0,14% | 34.363 NS | 30. April 2026 | N-PORT |
| IWS · iShares Trust | 0,14% | 294.321 SH | 8. August 2026 | Täglich |
| APUE · Trust for Professional Managers | 0,13% | 55.777 NS | 31. Mai 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,13% | 8.292 NS | 31. Mai 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,11% | 235.114 NS | 30. April 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,11% | 7.335 NS | 30. April 2026 | N-PORT |
| BSMT · Invesco Exchange-Traded Self-Indexe… | 0,10% | 270.000 | 8. August 2026 | Täglich |
| IWR · iShares Trust | 0,10% | 792.812 SH | 8. August 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 11.432 SH | 8. August 2026 | Täglich |
| BSMS · Invesco Exchange-Traded Self-Indexe… | 0,08% | 255.000 | 8. August 2026 | Täglich |
| VLUE · iShares Trust | 0,08% | 104.586 SH | 8. August 2026 | Täglich |
| XOEF · iShares Trust | 0,08% | 245 SH | 8. August 2026 | Täglich |
| CAPE · DoubleLine ETF Trust | 0,07% | 2.453 NS | 31. März 2026 | N-PORT |
| BSMR · Invesco Exchange-Traded Self-Indexe… | 0,06% | 215.000 | 8. August 2026 | Täglich |
| BAB · Invesco Exchange-Traded Fund Trust … | 0,06% | 582.000 | 8. August 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,06% | 7.148 SH | 8. August 2026 | Täglich |
| JSTC · Tidal Trust I | 0,05% | 3.001 NS | 31. Mai 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,05% | 44.755 SH | 8. August 2026 | Täglich |
| IVE · iShares Trust | 0,05% | 324.351 SH | 8. August 2026 | Täglich |